Page 5 - உலகளாவிய வெளிப்புறம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உலகளாவிய வெளிப்புறம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உலகளாவிய வெளிப்புறம் Today - Breaking & Trending Today

INVENTIVA: Inventiva to participate at the Jefferies Virtual Healthcare Conference


INVENTIVA: Inventiva to participate at the Jefferies Virtual Healthcare Conference
Daix
(France), May 25, 2021 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced that the Company will participate to the upcoming Jefferies Virtual Healthcare Conference, being held virtually on June 1-4, 2021. During the event, members of the Company s leadership will present a corporate overview, participate in a fireside chat and engage in 1x1 investor meetings.
The event details are as follows: ....

Pascaline Clerc , David Nikodem , Yannick Tetzlaff , Aude Lepreux , Patricial Bank , Brunswick Group , Global External Affairs , Euronext Paris , Jefferies Virtual Healthcare Conference , Vice President , Breakthrough Therapy , Fast Track , Global External , Roquet Montegon , Virtual Healthcare Conference , பிரன்சுவிக் குழு , உலகளாவிய வெளிப்புறம் வாழ்க்கைத்தொழில்கள் , ஜெஃப்பெரிஸ் மெய்நிகர் சுகாதாரம் மாநாடு , துணை ப்ரெஸிடெஂட் , திருப்புமுனை சிகிச்சை , வேகமாக டிராக் , உலகளாவிய வெளிப்புறம் , மெய்நிகர் சுகாதாரம் மாநாடு ,

INVENTIVA: Inventiva reports first quarter 2021 financial information and updates on the collaboration with AbbVie in auto-immune diseases


INVENTIVA: Inventiva reports first quarter 2021 financial information and updates on the collaboration with AbbVie in auto-immune diseases
Revenues of €0.1m in Q1 2021
Decision by AbbVie to move into Phase IIb clinical development with cedirogant in psoriasis, following promising results in its Phase Ib clinical trial
Daix (France), May 12, 2021 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today reported its cash position as of March 31, 2021 and its revenues for the first quarter of 2021, and provided an update on its collaboration with AbbVie in auto-immune diseases. ....

France General , City Of , United Kingdom , Pascaline Clerc , Yannick Tetzlaff , Aude Lepreux , Patricial Bank , Brunswick Group , Exchange Commission On , Global External Affairs , Portzampac Health Biotech Seminar , International Liver Congress , Euronext Paris , Non Alcoholic Fatty Liver Disease , Virtual Healthcare Conference , Cyberx Series , Liver Disease Day , Annual Biopharma Conference , Annual Global Investment Conference , Health Biotech Seminar , Healthcare Conference , Liver Congress , Liver Meeting , Breakthrough Therapy , Fast Track , Global External ,

Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva reports first quarter 2021 financial information and updates on the collaboration with AbbVie in auto-immune diseases


Important Notice
This press release contains forward-looking statements, forecasts and estimates with respect to Inventiva’s clinical trials, clinical trial data releases, clinical development plans and anticipated future activities of Inventiva. Certain of these statements, forecasts and estimates can be recognized by the use of words such as, without limitation, “believes”, “anticipates”, “expects”, “intends”, “plans”, “seeks”, “estimates”, “may”, “will” and “continue” and similar expressions. Such statements are not historical facts but rather are statements of future expectations and other forward-looking statements that are based on management s beliefs. These statements reflect such views and assumptions prevailing as of the date of the statements and involve known and unknown risks and uncertainties that could cause future results, performance or future events to differ materially from those expressed or implied in such statemen ....

United States , France General , City Of , United Kingdom , Pascaline Clerc , Yannick Tetzlaff , Aude Lepreux , Patricial Bank , Brunswick Group , Exchange Commission On , Global External Affairs , Portzampac Health Biotech Seminar , International Liver Congress , Euronext Paris , Non Alcoholic Fatty Liver Disease , Virtual Healthcare Conference , Cyberx Series , Liver Disease Day , Annual Biopharma Conference , Annual Global Investment Conference , Health Biotech Seminar , Healthcare Conference , Liver Congress , Liver Meeting , Breakthrough Therapy , Fast Track ,

Allison Transmissions eGen Flex Electric Hybrid Solution Introduced in New York City Transit Buses


Posted on
205
Allison Transmission, a leading designer and manufacturer of vehicle propulsion solutions for commercial and defense vehicles, the largest global manufacturer of medium and heavy-duty fully automatic transmissions, and a leader in electrified propulsion systems, is pleased to announce that the eGen Flex™, its next generation electric hybrid propulsion solution, will be put into revenue service at New York City Transit (NYCT) in May.
Allison Transmission’s eGen Flex, its next generation electric hybrid propulsion solution, will be put into revenue service at New York City Transit (NYCT) in May (Photo: Business Wire)
The electric hybrid system from Allison offers revolutionary capabilities and fully electric propulsion when customers need it, without the added infrastructure requirements of full electrification. The eGen Flex system includes full electric drive capability for up to 10 mil ....

New York , United States , Claire Gregory , Rohan Barua , York City Transit Authority , Global External Communications , Allison Transmission , Gen Flex , New York City Transit , Business Wire , Vice President , North America , New York City Transit Authority , Global External , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , கிளாரி கிரெகொரி , ரோஹன் பெருஞ் , யார்க் நகரம் போக்குவரத்து அதிகாரம் , உலகளாவிய வெளிப்புறம் தகவல்தொடர்புகள் , அல்லிசன் பரவும் முறை , கேன் நெகிழ்வு , புதியது யார்க் நகரம் போக்குவரத்து , வணிக கம்பி , துணை ப்ரெஸிடெஂட் , வடக்கு அமெரிக்கா ,